142818-02-8 Usage
Description
1-(TERT-BUTYL)-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID is a specialized chemical compound that belongs to the synthetic class of pyrazoles. It is characterized by the presence of a tert-butyl group, a trifluoromethyl group, and a carboxylic acid group, making it a multifunctional molecule. Its molecular formula is C10H12F3NO2, which indicates that it is composed of carbon, hydrogen, fluorine, nitrogen, and oxygen. 1-(TERT-BUTYL)-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID is known for its potential applications in medicinal chemistry and chemical research.
Uses
Used in Pharmaceutical Industry:
1-(TERT-BUTYL)-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and functional groups make it a valuable building block for the development of new drugs, particularly in the area of medicinal chemistry.
Used in Chemical Research:
1-(TERT-BUTYL)-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID is used as a research compound in various chemical studies. Its multifunctional nature allows for exploration of its properties and potential reactions, contributing to the advancement of chemical knowledge and the discovery of new applications.
Check Digit Verification of cas no
The CAS Registry Mumber 142818-02-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,8,1 and 8 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 142818-02:
(8*1)+(7*4)+(6*2)+(5*8)+(4*1)+(3*8)+(2*0)+(1*2)=118
118 % 10 = 8
So 142818-02-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H11F3N2O2/c1-8(2,3)14-6(9(10,11)12)5(4-13-14)7(15)16/h4H,1-3H3,(H,15,16)
142818-02-8Relevant articles and documents
Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase
-
Page/Page column 18; 34, (2008/06/13)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.
